Clinical Trial Update: WEUKBRE5716: Steroid-related Damage in Systemic Lupus Erythematosus (Hopkins)

View source ↗

Summary

GlaxoSmithKline-sponsored clinical trial WEUKBRE5716 investigating steroid-related damage in systemic lupus erythematosus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: GlaxoSmithKline | Conditions: Systemic Lupus Erythematosus | Status: COMPLETED